LEGISLATIVE BUDGET BOARD Austin, Texas FISCAL NOTE, 81ST LEGISLATIVE REGULAR SESSION May 19, 2009 TO: Honorable David Dewhurst, Lieutenant Governor, Senate FROM: John S. O'Brien, Director, Legislative Budget Board IN RE:SB39 by Zaffirini (Relating to health benefit plan coverage for routine patient care costs for enrollees participating in certain clinical trials.), As Passed 2nd House Estimated Two-year Net Impact to General Revenue Related Funds for SB39, As Passed 2nd House: a negative impact of ($601,403) through the biennium ending August 31, 2011. The bill would make no appropriation but could provide the legal basis for an appropriation of funds to implement the provisions of the bill.
LEGISLATIVE BUDGET BOARD
Austin, Texas
FISCAL NOTE, 81ST LEGISLATIVE REGULAR SESSION
May 19, 2009
TO: Honorable David Dewhurst, Lieutenant Governor, Senate FROM: John S. O'Brien, Director, Legislative Budget Board IN RE:SB39 by Zaffirini (Relating to health benefit plan coverage for routine patient care costs for enrollees participating in certain clinical trials.), As Passed 2nd House
TO: Honorable David Dewhurst, Lieutenant Governor, Senate
FROM: John S. O'Brien, Director, Legislative Budget Board
IN RE: SB39 by Zaffirini (Relating to health benefit plan coverage for routine patient care costs for enrollees participating in certain clinical trials.), As Passed 2nd House
Honorable David Dewhurst, Lieutenant Governor, Senate
Honorable David Dewhurst, Lieutenant Governor, Senate
John S. O'Brien, Director, Legislative Budget Board
John S. O'Brien, Director, Legislative Budget Board
SB39 by Zaffirini (Relating to health benefit plan coverage for routine patient care costs for enrollees participating in certain clinical trials.), As Passed 2nd House
SB39 by Zaffirini (Relating to health benefit plan coverage for routine patient care costs for enrollees participating in certain clinical trials.), As Passed 2nd House
Estimated Two-year Net Impact to General Revenue Related Funds for SB39, As Passed 2nd House: a negative impact of ($601,403) through the biennium ending August 31, 2011. The bill would make no appropriation but could provide the legal basis for an appropriation of funds to implement the provisions of the bill.
Estimated Two-year Net Impact to General Revenue Related Funds for SB39, As Passed 2nd House: a negative impact of ($601,403) through the biennium ending August 31, 2011.
The bill would make no appropriation but could provide the legal basis for an appropriation of funds to implement the provisions of the bill.
General Revenue-Related Funds, Five-Year Impact: Fiscal Year Probable Net Positive/(Negative) Impact to General Revenue Related Funds 2010 $0 2011 ($601,403) 2012 ($661,543) 2013 ($721,683) 2014 ($781,823)
2010 $0
2011 ($601,403)
2012 ($661,543)
2013 ($721,683)
2014 ($781,823)
All Funds, Five-Year Impact: Fiscal Year Probable Savings/(Cost) fromGeneral Revenue Fund1 Probable Savings/(Cost) fromGR Dedicated Accounts994 Probable Savings/(Cost) fromOther Special State Funds998 Probable Savings/(Cost) fromState Highway Fund6 2010 $0 $0 $0 $0 2011 ($601,403) ($24,910) ($2,634) ($136,967) 2012 ($661,543) ($27,401) ($2,897) ($150,664) 2013 ($721,683) ($29,892) ($3,160) ($164,361) 2014 ($781,823) ($32,383) ($3,424) ($178,057) Fiscal Year Probable Savings/(Cost) fromFederal Funds555 2010 $0 2011 ($134,486) 2012 ($147,935) 2013 ($174,832) 2014 ($129,480)
Fiscal Year Probable Savings/(Cost) fromGeneral Revenue Fund1 Probable Savings/(Cost) fromGR Dedicated Accounts994 Probable Savings/(Cost) fromOther Special State Funds998 Probable Savings/(Cost) fromState Highway Fund6 2010 $0 $0 $0 $0 2011 ($601,403) ($24,910) ($2,634) ($136,967) 2012 ($661,543) ($27,401) ($2,897) ($150,664) 2013 ($721,683) ($29,892) ($3,160) ($164,361) 2014 ($781,823) ($32,383) ($3,424) ($178,057)
2010 $0 $0 $0 $0
2011 ($601,403) ($24,910) ($2,634) ($136,967)
2012 ($661,543) ($27,401) ($2,897) ($150,664)
2013 ($721,683) ($29,892) ($3,160) ($164,361)
2014 ($781,823) ($32,383) ($3,424) ($178,057)
Fiscal Year Probable Savings/(Cost) fromFederal Funds555 2010 $0 2011 ($134,486) 2012 ($147,935) 2013 ($174,832) 2014 ($129,480)
2010 $0
2011 ($134,486)
2012 ($147,935)
2013 ($174,832)
2014 ($129,480)
Fiscal Analysis
The bill would amend the Insurance Code to require health insurance plans to provide coverage for routine patient care costs for enrollees participating in certain clinical trials. The bill would take effect September 1, 2009, and would apply to all health plans delivered or renewed on or after January 1, 2010.
The bill would amend the Insurance Code to require health insurance plans to provide coverage for routine patient care costs for enrollees participating in certain clinical trials.
The bill would take effect September 1, 2009, and would apply to all health plans delivered or renewed on or after January 1, 2010.
Methodology
Based on the actuarial analysis of the Employees Retirement System (ERS), it is assumed the bill would result in a cost increase of 0.05 percent to the ERS Group Benefits Program (GBP) and that costs would total amounts in the table above. The additional cost is assumed to increase each year in accordance with the benefit cost trend of 7.5 percent per year. Based on the analysis of the Texas Department of Insurance (TDI), it is assumed that there would be a one-time revenue gain of $8,880 in the General Revenue Dedicated Account Fund 36 in fiscal year 2010 because the bill would result in filings of amendments to reflect this change of law by insurers. Since General Revenue Dedicated Account Fund 36 is a self-leveling account, this analysis assumes all general revenue would go toward fund balances or the maintenance tax would be set to recover a lower level of revenue the following year. It is also assumed that any costs realized by TDI from implementing the provisions of the bill could be absorbed within existing resources. Based on the analysis by the Teachers Retirement System, both TRS-Care and TRS ActiveCare insurance plans currently provide benefits for medically necessary routine care patient costs incurred concurrently with a clinical trial. It is anticipated that there would be no significant impact from implementation of the bill.
Based on the actuarial analysis of the Employees Retirement System (ERS), it is assumed the bill would result in a cost increase of 0.05 percent to the ERS Group Benefits Program (GBP) and that costs would total amounts in the table above. The additional cost is assumed to increase each year in accordance with the benefit cost trend of 7.5 percent per year.
Based on the analysis of the Texas Department of Insurance (TDI), it is assumed that there would be a one-time revenue gain of $8,880 in the General Revenue Dedicated Account Fund 36 in fiscal year 2010 because the bill would result in filings of amendments to reflect this change of law by insurers. Since General Revenue Dedicated Account Fund 36 is a self-leveling account, this analysis assumes all general revenue would go toward fund balances or the maintenance tax would be set to recover a lower level of revenue the following year. It is also assumed that any costs realized by TDI from implementing the provisions of the bill could be absorbed within existing resources.
Based on the analysis by the Teachers Retirement System, both TRS-Care and TRS ActiveCare insurance plans currently provide benefits for medically necessary routine care patient costs incurred concurrently with a clinical trial. It is anticipated that there would be no significant impact from implementation of the bill.
Local Government Impact
No significant fiscal implication to units of local government is anticipated.
Source Agencies: 323 Teacher Retirement System, 327 Employees Retirement System, 454 Department of Insurance
323 Teacher Retirement System, 327 Employees Retirement System, 454 Department of Insurance
LBB Staff: JOB, SD, KJG, MS, DEH, CH, JW
JOB, SD, KJG, MS, DEH, CH, JW